In Vitro Fertilization (IVF) has made revolutionary changes within the last 10 years. The most recent focus is on being able to make sure each pregnancy we achieve is a normal pregnancy and will lead to a normal baby. Current technology allows for testing of the embryos through a precise biopsy of the embryo that will undergo a preimplantation screening. A preimplantation screening of the embryos will test for abnormalities such as Down syndrome and other chromosomal abnormalities. This technology allows for the transfer of only chromosomally normal embryos which therefore increases the likelihood of a successful embryo transfer and successful pregnancy.
Here at Generation Next Fertility, we are proud to offer to our patients Preimplantation Genetic Testing for Aneuploidies (PGT-A), Preimplantation Genetic screening (PGS) and Preimplantation Genetic Diagnosis (PGD).
What type of conditions can be screened for using Preimplantation Genetic Testing for Aneuploidies (PGT-A)?
There are a number of chromosomal abnormalities that can be identified during the PGT-A process. These include alterations in the number of chromosomes, leading to conditions such as Down syndrome, Turner’s syndrome, and unbalanced chromosome complements that result from structural chromosome rearrangements in the parents’ genes that can cause birth defects, mental retardation and/or miscarriage. PGT-A provides our patients with the ability to transfer normal embryos, while also making them aware of any abnormal embryos they may have. Preimplantation genetics not only provides you with the chromosomal analysis of the embryos, but will also allow for gender selection.